Systems Saving Lives - Long-term Survival of Out-of-hospital Cardiac Arrest in the Urban Area of Bologna (SSL)

February 15, 2022 updated by: Azienda Usl di Bologna

Systems Saving Lives - Long-term Survival of Out-of-hospital Cardiac Arrest in the Urban Area of Bologna Following the Implementation of the Pre-arrival Instructions, the DAE RespondER, Mechanical Chest Compressors and Circulatory Support With REBOA and ECMO

Evaluation of clinical, logistical, and technical factors (e.g. implementation of pre-arrival instructions, implementation of the DAE RespondER, mechanical chest compressor, REBOA, and E-CPR) that impact on the outcomes of out-of-hospital cardiac arrest patients.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Anticipated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Bologna, Italy, 40110
        • Recruiting
        • Maggiore Hospital Ospedale Maggiore Carlo Alberto Pizzardi AUSL di Bologna
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Lorenzo Gamberini, MD
        • Sub-Investigator:
          • Marco Tartaglione, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 120 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Population served by EMS of Bologna area

Description

Inclusion Criteria:

  • Out of Hospital cardiac arrest patients (historical cohort) from 1st January 2009 and 30th June 2020
  • Out of Hospital cardiac arrest patients from 1st July 2020 and 31st December 2025

Exclusion Criteria:

  • False cardiac arrest
  • In-hospital cardiac arrest

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
cardiac arrest

Out of hospital cardiac arrest patients (Historical cohort) from 1st January 2009 and 30th June 2020.

Out of hospital cardiac arrest patients from 1st July 2020 and 31st December 2025.

Observational study with standard cardiac arrest approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ROSC (Return of spontaneous circulation)
Time Frame: 1st July 2020 to 31st December 2025
ROSC (Return of spontaneous circulation) of cardiac arrest patients
1st July 2020 to 31st December 2025
Hospital admission status
Time Frame: 1st July 2020 to 31st December 2025
Hospital admission status of cardiac arrest patients
1st July 2020 to 31st December 2025
Hospital discharge status/survival at 30 days
Time Frame: 30 days
Hospital discharge status/survival at 30 days of cardiac arrest patients
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival at 6 months
Time Frame: 6 months
Survival at 6 months of cardiac arrest patients
6 months
Survival at 1 years
Time Frame: 1 year
Survival at 1 years of cardiac arrest patients
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Federico F Semeraro, MD, FERC, Maggiore Hospital Carlo Alberto Pizzardi AUSL di Bologna

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2020

Primary Completion (ACTUAL)

July 1, 2021

Study Completion (ANTICIPATED)

December 31, 2025

Study Registration Dates

First Submitted

July 9, 2020

First Submitted That Met QC Criteria

August 11, 2020

First Posted (ACTUAL)

August 12, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 16, 2022

Last Update Submitted That Met QC Criteria

February 15, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 1.0

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest

Clinical Trials on Observational study without specific intervention

Subscribe